The Company’s estimated accrued liability for the above-described opioid-related claims of U.S. governmental entities, including Native American tribes, and certain non-governmental plaintiffs, including a settlement with certain third-party payors and a nationwide class of acute care hospitals, was as follows:


(In millions)	June 30, 2026		March 31, 2026
Current litigation liabilities (1)	$	602	$	601
Long-term litigation liabilities	5,058		5,091

Total litigation liabilities	$	5,660	$	5,692

(1)These amounts, recorded within “Other accrued liabilities” in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.